본문 바로가기
KERD
논문KCI 등재

Gastroparesis: Current Concepts and Management

Jan Tack|Tatsuhiro Masaoka
거트앤리버 소화기연관학회협의회|2009.09|Gut and Liver|제3권 제3호|pp. 166-173

2

조회

0

다운로드

1

인용

0

참고문헌

초록

Delayed gastric emptying in the absence of mechanical obstruction is referred to as gastroparesis. Symptoms that are often attributed to gastroparesis include postprandial fullness, nausea, and vomiting. Although tests of gastric motor function may aid diagnostic labeling, their contribution to determining the treatment approach is often limited. Although clinical suspicion of gastroparesis warrants the exclusion of mechanical causes and serum electrolyte imbalances, followed by empirical treatment with a gastroprokinetic such as domperidone or metoclopramide, evidence that these drugs are effective for patients with gastroparesis is far from overwhelming. In refractory cases with severe weight loss, invasive therapeutics such as inserting a feeding jejunostomy tube, intrapyloric injection of botulinum toxin, surgical (partial) gastrectomy, and implantable gastric electrical stimulation are occasionally considered.

Abstract

Delayed gastric emptying in the absence of mechanical obstruction is referred to as gastroparesis. Symptoms that are often attributed to gastroparesis include postprandial fullness, nausea, and vomiting. Although tests of gastric motor function may aid diagnostic labeling, their contribution to determining the treatment approach is often limited. Although clinical suspicion of gastroparesis warrants the exclusion of mechanical causes and serum electrolyte imbalances, followed by empirical treatment with a gastroprokinetic such as domperidone or metoclopramide, evidence that these drugs are effective for patients with gastroparesis is far from overwhelming. In refractory cases with severe weight loss, invasive therapeutics such as inserting a feeding jejunostomy tube, intrapyloric injection of botulinum toxin, surgical (partial) gastrectomy, and implantable gastric electrical stimulation are occasionally considered.

참고문헌 (63)

  1. Tack J, "Gastric motor disorders", Best Pract Res Clin Gastroenterol, 21, pp.633~644 (2007)
  2. Sanders KM, "Interstitial cells of cajal as pacemakers in the gastrointestinal tract", Annu Rev Physiol, 68, pp.307~343 (2006)
  3. Vantrappen G, "The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine", J Clin Invest, 59, pp.1158~1166 (1977)
  4. Azpiroz F, "Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis", Gastroenterology, 92, pp.934~943 (1987)
  5. Schuurkes JA, "Nitric oxide and gastric relaxation", Dig Dis Sci, 39, pp.79S~81S (1994)
  6. Takahashi T, "Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract", J Gastroenterol, 38, pp.421~430 (2003)
  7. Tack J, "Role of impaired gastric accommodation to a meal in functional dyspepsia", Gastroenterology, 115, pp.1346~1352 (1998)
  8. Abell TL, "Treatment of gastroparesis: a multidisciplinary clinical review", Neurogastroenterol Motil, 18, pp.263~283 (2006)
  9. Vecht JA, "The dumping syndrome: current insights into pathophysiology, diagnosis and treatment", Scand J Gastroenterol Suppl, 223, pp.21~27 (1997)
  10. Stanghellini V, "Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia", Gastroenterology, 110, pp.1036~1042 (1996)
  11. Tack J, "The difficult patient with gastroparesis", Best Pract Res Clin Gastroenterol, 21, pp.379~391 (2007)
  12. Datz FL, "Gender-related differences in gastric emptying", J Nucl Med, 28, pp.1204~1207 (1987)
  13. Soykan I, "Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis", Dig Dis Sci, 43, pp.2398~2404 (1998)
  14. Geeraerts B, "Influence of abuse history on gastric sensorimotor function in func tional dyspepsia", Neurogastroenterol Motil, 21, pp.33~41 (2009)
  15. Horowitz M, "Gastroparesis: prevalence, clinical significance and treatment", Can J Gastroenterol, 15, pp.805~813 (2001)
  16. Patrick A, "Review article: gastroparesis", Aliment Pharmacol Ther, 27, pp.724~740 (2008)
  17. Parkman HP, "American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis", Gastroenterology, 127, pp.1592~1622 (2004)
  18. Tougas G, "Assessment of gastric emptying using a low fat meal: establishment of international control values", Am J Gastroenterol, 95, pp.1456~1462 (2000)
  19. Piessevaux H, "Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms", Neurogastroenterol Motil, 15, pp.447~455 (2003)
  20. Ghoos YF, "Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test", Gastroenterology, 104, pp.1640~1647 (1993)
  21. Chew CG, "Simultaneous 13C", 14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy, 2003, pp.6, 29~33
  22. Zahn A, "Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics", Z Gastroenterol, 41, pp.383~390 (2003)
  23. Schwizer W, "Measurement of gastric emptying by magnetic resonance imaging in humans", Gastroenterology, 103, pp.369~376 (1992)
  24. Lauenstein TC, "Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin", AJR Am J Roentgenol, 180, pp.1305~1310 (2003)
  25. Jones KL, "A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus", Am J Med, 113, pp.449~455 (2002)
  26. Moore SA, "Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats", J Neurol Sci, 52, pp.289~303 (1981)
  27. Schvarcz E, "Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus", Gastroenterology, 113, pp.60~66 (1997)
  28. Petrakis IE, "Hyperglycaemia attenuates erythromycininduced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis", Scand J Gastroenterol, 34, pp.396~403 (1999)
  29. Horowitz M, "Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis", Digestion, 65, pp.41~46 (2002)
  30. Corinaldesi R, "Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis", Gut, 28, pp.300~305 (1987)
  31. Finney JS, "Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia", J Clin Gastroenterol, 26, pp.312~320 (1998)
  32. Sturm A, "Prokinetics in patients with gastroparesis: a systematic analysis", Digestion, 60, pp.422~427 (1999)
  33. Veldhuyzen van Zanten SJ, "Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis", Am J Gastroenterol, 96, pp.689~696 (2001)
  34. Braden B, "Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control", Aliment Pharmacol Ther, 16, pp.1341~1346 (2002)
  35. Stacher G, "Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial", J Clin Endocrinol Metab, 84, pp.2357~2362 (1999)
  36. Tack J, "Prokinetics and fundic relaxants in upper functional GI disorders", Curr Opin Pharmacol, 8, pp.690~696 (2008)
  37. Schuurkes J, "Effect of cisapride on gastric motility", Z Gastroenterol, 28(1), pp.27~30 (1990)
  38. Dumitrascu DL, "Domperidone versus metoclopramide in the treatment of diabetic gastroparesis", Am J Gastroenterol, 95, pp.316~317 (2000)
  39. Patterson D, "A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis", Am J Gastroenterol, 94, pp.1230~1234 (1999)
  40. Feldman M, "Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum: a comparison with metoclopramide and placebo", Gastroenterology, 92, pp.171~174 (1987)
  41. Michalets EL, "Drug interactions with cisapride: clinical implications", Clin Pharmacokinet, 39, pp.49~75 (2000)
  42. Janssens J, "Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies", N Engl J Med, 322, pp.1028~1031 (1990)
  43. Maganti K, "Oral erythromycin and symptomatic relief of gastroparesis: a systematic review", Am J Gastroenterol, 98, pp.259~263 (2003)
  44. Talley NJ, "Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial", Gut, 49, pp.395~401 (2001)
  45. Talley NJ, "Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial", Aliment Pharmacol Ther, 14, pp.1653~1661 (2000)
  46. Devendra D, "Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy", Diabetes Care, 23, pp.426~427 (2000)
  47. Jacober SJ, "Jejunostomy feeding in the management of gastroparesis diabeticorum", Diabetes Care, 9, pp.217~219 (1986)
  48. Fontana RJ, "Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review", Am J Gastroenterol, 91, pp.2174~2178 (1996)
  49. Ezzeddine D, "Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis", Gastrointest Endosc, 55, pp.920~923 (2002)
  50. Miller LS, "Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle", Am J Gastroenterol, 97, pp.1653~1660 (2002)
  51. Arts J, "Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients", Aliment Pharmacol Ther, 24, pp.661~667 (2006)
  52. Arts J, "Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis", Aliment Pharmacol Ther, 26, pp.1251~1258 (2007)
  53. Friedenberg FK, "Botulinum toxin A for the treatment of delayed gastric emptying", Am J Gastroenterol, 103, pp.416~423 (2008)
  54. Jones MP, "A systematic review of surgical therapy for gastroparesis", Am J Gastroenterol, 98, pp.2122~2129 (2003)
  55. Kim CH, "Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis", Gastrointest Endosc, 47, pp.67~70 (1998)
  56. Forstner-Barthell AW, "Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients", J Gastrointest Surg, 3, pp.15~21 (1999)
  57. Abell TL, "Gastric electrical stimulation in intractable symptomatic gastroparesis", Digestion, 66, pp.204~212 (2002)
  58. Jones MP, "Gastric electrical stimulation for refractory gastroparesis", Gastroenterology, 126, pp.629~630 (2004)
  59. Abell T, "Gastric electrical stimulation for medically refractory gastroparesis", Gastroenterology, 125, pp.421~428 (2003)
  60. Gourcerol G, "Gastric electrical stimulation in medically refractory nausea and vomiting", Eur J Gastroenterol Hepatol, 19, pp.29~35 (2007)
  61. Ang D, "Gastric electrical stimulation for the treatment of gastroparesis: ready for prime time?", Digestion, 75, pp.80~82 (2007)
  62. Lin Z, "Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation", Diabetes Care, 27, pp.1071~1076 (2004)
  63. van der Voort IR, "Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis", Exp Clin Endocrinol Diabetes, 113, pp.38~42 (2005)

관련 논문AI추천

Gastroparesis Updates on Pathogenesis and ManagementNanlong Liu, Thomas Abell거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제5호A New Paradigm Shift in Gastroparesis ManagementMekaroonkamol Parit, Rerknimitr Rungsun, Tiankanon Kasenee거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제6호Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and TreatmentEsquivel Micaela M., Gottfried-Blackmore Andres, Hwang Joo Ha, Joseph Abel A., Li Andrew A., Na Hee Kyong, Nguyen Linda, Podboy Alexander J.거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제3호Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis조수정, Hyun Jung Lee, Hyunsoo Chung, Jaeyoung Chun, Jihye Kim, Jong Pil Im, Joo Sung Kim, Jooyoung Lee, Sang Gyun Kim, Seung Wook Hong거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호Post-surgical gastroparesis and beyond: The expanding role of G-POEM in foregut surgery complications and obesity careAlexander Joseph Podboy, Christopher Farid, Joselyne Tessa Tonleu소화기인터벤션의학회 · International Journal of Gastrointestinal Intervention2025 · 제14권 제4호Technical review of gastric per-oral endoscopic myotomyAlexander Podboy, Joo Ha Hwang소화기인터벤션의학회 · International Journal of Gastrointestinal Intervention2019 · 제8권 제3호

이 간행물의 다른 논문 (14건)

Liver TransplantationSung-Gyu Lee, Deok-Bog Moonpp. 145-165The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel SyndromeKyoung Hee Won, 박정호, 전우규, 박동일, 김홍주, 손정일, 김병익, 조용균, Soon Min Parkpp. 174-179Bowel Preparation for Capsule Endoscopy: A Prospective Randomized Multicenter StudyJi-Kon Ryu, 김진오, 심기남, 도재혁, 전훈재, Kwang Jae Lee, Byung Ik Jang, Myung-Gyu Choi, Jun-Hwan Wi, Jeong-Seop Moonpp. 180-185Risk Factors for Food Residue after Distal Gastrectomy and a New Effective Preparation for Endoscopy: The Water-Intake MethodKyoung-Won Yoon, Chang-Hwan Park, Hyun-Soo Kim, Jong-Sun Rew, Seon-Young Park, Sung-Kyu Choi, Sung-Bum Cho, Young-Eun Joo, Wan-Sik Leepp. 186-191Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel SyndromeKazutoshi Hori, Takayuki Matsumoto, Hiroto Miwapp. 192-196
원문 보기